Risk Materials

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

Renal and Bone Effects Risk Minimisation Material Tenofovir Disoproxil for Children and Adolescents with HIV-1

This brochure contains important advice on the management of potential renal and bone effects of tenofovir disoproxil in HIV-1 infected children and adolescents aged 2 to <18 years, and the dosing recommendations for tenofovir disoproxil in this population.

For Healthcare Professionals

Renal Risk Minimisation Material Tenofovir Disoproxil for Adolescent Children with Chronic Hepatitis B

This brochure provides important advice on the management of potential renal and bone effects of Tenofovir disoproxil in adolescent patients with chronic hepatitis B aged 12 to <18 years, and on the dosing recommendations for tenofovir disoproxil in this population.

For Healthcare Professionals

Send us feedback

If you would like to make a comment or send us feedback on this material, click here.